Plasma TIMP-I - A marker of metastasis in colorectal cancer

Colorectal Disease

Volumn 2, Issue 2, 2000, Pages 100-105

  Simpson, R A ^a   Hemingway, D M ^a   Thompson, M M ^a  

^a LEICESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Colorectal cancer; Metastasis; MMP 9; TIMP I

Indexed keywords

BIOCHEMICAL MARKER; GELATINASE B; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

AGED; ARTICLE; BLOOD SAMPLING; CANCER INVASION; CANCER LOCALIZATION; CANCER STAGING; CLINICAL ARTICLE; CLINICAL FEATURE; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE SEVERITY; ENZYME BLOOD LEVEL; HUMAN; LAPAROTOMY; METASTASIS; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

EID: 0034529623     PISSN: 14628910     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1463-1318.2000.00123.x     Document Type: Article

References (30)

1. Clinical applications of serum tumour markers
2. Expression and localisation of matrix degrading metalloproteinase during colorectal tumourogenesis
3. Distribution of collagenase and tissue inhibitor of metalloproteinase (TIMP) in colorectal tumours
4. 92 kDa type IV collagenase (MMP-9) is expressed in neutrophils and macrophages but not in malignant epithelial cells in human colon cancer
5. Distribution of Gelatinase B (MMP-9) and type IV collagen in colorectal carcinoma
6. Gelatinase (MMP-2 and -9) expression in gastrointestinal malignancy
7. Tumour cell interactions with the extracellular matrix during invasion and metastasis
8. The matrix metalloproteinases and their inhibitors
9. Cancer invasion and metastasis. Positive and negative regulatory elements
10. Prognostic values of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression in bladder cancer
11. Tissue inhibitor of metalloproteinase-1 (TIMP-1) RNA is expressed at elevated levels in malignant non-Hodgkin's lymphomas
12. Growth-promoting activity of tissue inhibitor of metalloproteinase-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum
13. Cell growth-promoting activity of tissue inhibitor of metalloproteinase-2 (TIMP-2)
14. Matrix metalloproteinase I and 3, tissue inhibitor of metalloproteinase-1 and the complex of metalloproteinase-1/tissue inhibitor in the plasma of patients with prostate cancer
15. Plasma concentration of matrix metalloproteinase-9 in gastric cancer
16. Serum levels of tissue inhibitor of metalloproteinases-1 (TIMP-1) in bladder cancer patients
17. Elevated plasma levels of matrix metalloproteinase-9 (92kd type IV collagenase/gelatinase B) in hepatocellular carcinoma
18. Prediction of colorectal cancer relapse and survival via tissue RNA levels of matrix metalloproteinase-9
19. Distinct pattern of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 mRNA expression in human colorectal cancer and liver metastases
20. Enhanced expression of tissue inhibitors of metalloproteinases in human colorectal tumours
21. Immunological quantification of levels of tissue inhibitor of metalloproteinase-1 in colorectal cancer
22. Mr 92,000 type IV collagenase is increased in plasma of patients with colon cancer and breast cancer
23. Activity of type IV collagenases in benign and malignant breast disease
24. Quantitation of TIMP-1 in plasma of healthy blood donors and patients with advanced cancer
25. Plasma assay of gelatinase B: Tissue inhibitor of metalloproteinase complexes in cancer
26. Tissue inhibitor of metalloproteinase (TIMP-2): A new member of the metalloproteinase family
27. Role of tissue inhibitor of metalloproteinase-2 (TIMP-2) in regulation of pro-gelatinase A activation catalysed by membrane-type matrix metalloproteinase-1 (MTI-MMP) in human cancer cells
28. TIMP-2 promotes activation of pro-gelatinase A by membrane-type 1 matrix metalloproteinase immobilised on agarose beads
29. Measurement of matrixmetalloproteinases and tissue inhibitors off metalloproteases in blood and tissues. Clinical and experimental applications